Release Date: 17/07/19 08:22 Summary: Investor Presentation - July 2019 Price Sensitive: Yes Download Document 8.4MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%